Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Multiple sclerosis and Ocrelizumab

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Multiple sclerosis and Ocrelizumab

Multiple sclerosis vs. Ocrelizumab

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. Ocrelizumab (trade name Ocrevus) is a humanized anti-CD20 monoclonal antibody.

Similarities between Multiple sclerosis and Ocrelizumab

Multiple sclerosis and Ocrelizumab have 9 things in common (in Unionpedia): CD20, Humanized antibody, Interferon beta-1a, Intravenous therapy, Monoclonal antibody, Ofatumumab, Progressive multifocal leukoencephalopathy, Rituximab, Systemic lupus erythematosus.

CD20

B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity.

CD20 and Multiple sclerosis · CD20 and Ocrelizumab · See more »

Humanized antibody

Humanized antibodies are antibodies from non-human species whose protein sequences have been modified to increase their similarity to antibody variants produced naturally in humans.

Humanized antibody and Multiple sclerosis · Humanized antibody and Ocrelizumab · See more »

Interferon beta-1a

Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS).

Interferon beta-1a and Multiple sclerosis · Interferon beta-1a and Ocrelizumab · See more »

Intravenous therapy

Intravenous therapy (IV) is a therapy that delivers liquid substances directly into a vein (intra- + ven- + -ous).

Intravenous therapy and Multiple sclerosis · Intravenous therapy and Ocrelizumab · See more »

Monoclonal antibody

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell.

Monoclonal antibody and Multiple sclerosis · Monoclonal antibody and Ocrelizumab · See more »

Ofatumumab

Ofatumumab (trade name Arzerra, also known as HuMax-CD20) is a fully human monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation.

Multiple sclerosis and Ofatumumab · Ocrelizumab and Ofatumumab · See more »

Progressive multifocal leukoencephalopathy

Progressive multifocal leukoencephalopathy (PML) is a rare and usually fatal viral disease characterized by progressive damage (-pathy) or inflammation of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal).

Multiple sclerosis and Progressive multifocal leukoencephalopathy · Ocrelizumab and Progressive multifocal leukoencephalopathy · See more »

Rituximab

Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer.

Multiple sclerosis and Rituximab · Ocrelizumab and Rituximab · See more »

Systemic lupus erythematosus

Systemic lupus erythematosus (SLE), also known simply as lupus, is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body.

Multiple sclerosis and Systemic lupus erythematosus · Ocrelizumab and Systemic lupus erythematosus · See more »

The list above answers the following questions

Multiple sclerosis and Ocrelizumab Comparison

Multiple sclerosis has 242 relations, while Ocrelizumab has 28. As they have in common 9, the Jaccard index is 3.33% = 9 / (242 + 28).

References

This article shows the relationship between Multiple sclerosis and Ocrelizumab. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »